Advisors Asset Management’s Medicines Co MDCO Stock Holding History

Advisors Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,772	Closed	-$130K	–	1878
2018 Q4	$130K	Sell	6,772 -6,189	-48%	-$144K	﹤0.01%	1301
2018 Q3	$388K	Sell	12,961 -8,567	-40%	-$323K	0.01%	1109
2018 Q2	$790K	Sell	21,528 -2,072	-9%	-$67.3K	0.01%	918
2018 Q1	$723K	Sell	23,600 -616	-3%	-$19.2K	0.01%	956
2017 Q4	$662K	Sell	24,216 -792	-3%	-$24.4K	0.01%	999
2017 Q3	$926K	Sell	25,008 -1,972	-7%	-$72.7K	0.02%	893
2017 Q2	$1.03M	Buy	26,980 +763	+3%	+$34K	0.02%	870
2017 Q1	$1.28M	Buy	26,217 +11,018	+72%	+$503K	0.02%	788
2016 Q4	$516K	Buy	15,199 +7,627	+101%	+$270K	0.01%	1099
2016 Q3	$286K	Buy	+7,572	New	+$285K	﹤0.01%	1264

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Advisors Asset Management's MDCO Position: Q1 2019 in Review

Advisors Asset Management sold out of Medicines Co (MDCO) in Q1 2019, closing a stake of 6,772 shares — an estimated $130K sold.

Advisors Asset Management first reported a position in MDCO in Q3 2016 and held it in 10 quarters. The position peaked at $1.28M in Q1 2017. 203 funds tracked by Wall St. Rank hold MDCO as of Q1 2019.

Advisors Asset Management reported no remaining Medicines Co position as of Q1 2019 after selling out during the quarter.
Advisors Asset Management sold 6,772 Medicines Co shares in Q1 2019, an estimated $130K.
Advisors Asset Management first reported a position in Medicines Co in Q3 2016 and held it in 10 quarters.
Advisors Asset Management's Medicines Co position peaked at $1.28M in Q1 2017.
203 funds tracked by Wall St. Rank held Medicines Co as of Q1 2019.

Based on Advisors Asset Management's 13F filing for Q1 2019, filed 15 May 2019.